跳至主要内容
临床试验/NCT05407857
NCT05407857招募中不适用

Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention (TaiPEI)

Taipei Medical University Shuang Ho Hospital2 个研究点 分布在 1 个国家目标入组 380 人开始时间: 2022年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
380
试验地点
2
主要终点
Change in cognition including individual cognitive domains, unit on a scale

研究概览

简要总结

A 3-arm randomized controlled trial of multi-modal non-pharmacological Intervention for preventing the risk of dementia in Taiwanese geriatric people

详细描述

This project proposes an intervention program for dementia prevention based on the Taiwanese model. The investigator(s) will screen the elderly who are not yet demented but are at high risk of dementia and will randomly allocate them into three groups (on site intervention group, remote intervention group, and control group) for a two-year multi-modal non-pharmacological intervention. All intervention groups will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol. The remote intervention group is designed for reducing the chances of person-to-person contact response to the current coronavirus disease 2019 (COVID-19) pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs. During the study period, each group will be regularly monitored the changes of cardiovascular risk factors, physical performance and cognitive function. The results of multimodal intervention mainly from Taipei and New Taipei City will establish the Taiwan FINGER model (TaiPEI) and will have the information of the conditions and feasibility achieved in Taiwan and implementation suggestions in the face of the epidemic. It can be subsequently applied to the brain/body health care institution and to the prevention of dementia and cardiovascular disease of elderly.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

We will avoid all the outcomes assessors knowing the allocation and intervention groups.

The participant will only know what treatment is applied until the start of the intervention. We will also suggest the participants not to discuss their interventions and restrict the chance of communication between different intervention groups.

入排标准

年龄范围
60 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • People over 60 without dementia
  • Agree to join the study and sign the consent form
  • The Modified Rankin Scale (MRS) scores between 0-1 points
  • Education level: elementary or higher education (6 years) or can read and write Chinese
  • Very early dementia screening scale (AD-8) < 2, or more than 2 points but without dementia diagnoses after refer to a neurologist.
  • Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) Risk Score: above 8; diagnosed with mild cognitive impairment (MCI) or subjective cognitive decline (SCD) in the past six months.

排除标准

  • Have been diagnosed with any kind of dementia
  • Suspected dementia patients or others who are not suitable to participate in the research assessed by a doctor at the first visit
  • Diseases affecting the safety of various interventional activities (such as remaining life less than two years, symptomatic heart/cerebrovascular disease within 6 months, vascular reperfusion or reconstruction-related surgery within one year, etc., malignant tumor within one year)
  • Severe blindness, hearing or communication impairment, or other difficulty in cooperating or completing assessments and interventions (especially exercise) in the study
  • Severe mental illnesses, including major depression disorder, or major neuromusculoskeletal disorders that are not suitable to join the study.
  • Drug or alcohol abuse in the last year
  • Overlapping with other interventional trials at the same time which may affect the evaluation results.

结局指标

主要结局

Change in cognition including individual cognitive domains, unit on a scale

时间窗: Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)

A composite z-score will be obtained from the neuropsychological tests evaluating multiple cognitive domains, including memory, language, process speed, visuospatial, and executive function.

次要结局

  • Change in physical functioning - Hand-grip strength, kg(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change in blood tests - fasting plasma glucose, mmol/L.(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change of Plasma amyloid beta, pg/mL(Before intervention (Baseline); During intervention (6th month and 24th month))
  • Change of Plasma tau, pg/mL(Before intervention (Baseline); During intervention (6th month and 24th month))
  • Change of nutrition intake, unit on a scale(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change in depressive symptoms, unit on a scale.(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change in blood tests - triglycerides, mmol/L.(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change in blood tests - Albumin, prealbumin, g/dL.(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change in physical assessment, unit on a scale(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change of the questionnaire regarding the nutrition, unit on a scale(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change in functioning level, unit on a scale(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))
  • Change in sleep symptoms, unit on a scale.(Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends))

研究者

发起方
Taipei Medical University Shuang Ho Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yi-Chun Kuan

Physician, Department of Neurology, Principal Investigator, Associate Professor

Taipei Medical University Shuang Ho Hospital

研究点 (2)

Loading locations...

相似试验